Drug Diversion Act of 2021 (H.R. 1899)

Summary

Creates clear rules for when a person's or company's permission to handle controlled drugs ends, such as when they die or close their business.

What problem does this solve?

Previously, there were no clear federal rules for what happens to a registration for controlled drugs when a person dies or a business closes. This law adds rules that automatically end the registration and require telling the government, which helps prevent misuse of leftover drugs.

What does this law do?

Automatic termination of registration

Specifies that a registration to handle controlled substances automatically ends if the registrant dies, ceases to exist, closes their business, or surrenders the registration.

Mandatory notification of closure

Requires a registrant who stops their legal existence or business practice to quickly inform the Attorney General in writing.

Restrictions on transferring registration

Prohibits the transfer or assignment of a registration to another person or entity without the written consent of the Attorney General.

Procedure for discontinuing business

Requires registrants who are closing their business to return their registration certificate, unused order forms, and other required documents to the Attorney General.

Who does this affect?

Pharmacies and medical practitioners
Drug manufacturers and distributors
Drug Enforcement Administration (DEA)

What is the real world impact?

•

Prevents misuse of controlled substances

Establishes clear procedures for when a registration to handle controlled substances ends. This helps prevent leftover drugs from being sold illegally when a business closes or a person dies.

When does this start?

The rules in this act became effective on November 10, 2021.